Partial-edentulism
Conditions
Brief summary
The main aim of this clinical trial is to analyze the survival rate of short-length implants (\<4.5 mm) in partial edentulism subjects. 6.5 mm length implants will be used as control arm. Additionally, others clinical parameters (marginal bone loss and prosthetic associated complications) will be measured.
Interventions
DEVICEBTI Implant
Placement of dental implants of 5.5 vs \>6.5 mm length
Sponsors
Fundación Eduardo Anitua
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Age ≥ 18 years * Clinical indication to place a prosthetic bridge supported by a maximum of 4 implants in the posterior sectors * Bone height in the area of interest sufficient to place implants 6.5mm length dental implants * Availability to be observed during the follow-up period * Signature of the informed consent
Exclusion criteria
* Need to perform bone augmentation surgery prior to implant placement surgery * Smokers (\> 10 cigarettes per day) * Patients with poorly controlled diabetes * Patients on chronic treatment with non-steroidal anti-inflammatory drugs * Patients receiving oral or intravenous bisphosphonates * Patients under chemotherapy or radiotherapy treatment * Patients receiving systemic corticosteroids
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Survival of implants | 1 year | Survival of implants at one year post-implantation |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Marginal bone loss | 1 year | Marginal bone loss at one year post-implantation |
| Incidence of bleeding on probing | 1 year | — |
| Incidence of prosthetic or implant complications | 1 year | — |
| Probing pocket depth | 1 year | — |
Countries
Spain
Outcome results
None listed